Mayur Ian Somaiya, CFO: NewAmsterdam Pharma NAMS Sell · Filed 01/22

Trade details

Type: Insider sale
Amount: $512,781.5
Shares · price: 15,422 sh · $33.25 a share
Held after: 82,744 sh
Stock: NewAmsterdam Pharma NAMS
Person: Mayur Ian SomaiyaCFO
Trade date: 26/01/21
Filed: 26/01/22
Days to filing: 1 days

Sold 15.7% of holdings

Share of holding sold: 15.7%

NewAmsterdam Pharma trades, last 26 weeks

What else happened in NewAmsterdam Pharma around then

Filed or reported within 30 days of the trade day · 25/12/22~02/20

Mayur Ian Somaiya's recent trades

Mayur Ian SomaiyaCFO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$1.3M
39,712 sh
$1.3M
Filed 01/22
Traded 01/20
Mayur Ian SomaiyaCFO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$823.4K
24,362 sh
$823.4K
Filed 01/22
Traded 01/21
Mayur Ian SomaiyaCFO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$634.8K
19,604 sh
$634.8K
Filed 01/22
Traded 01/20
Mayur Ian SomaiyaCFO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$27.6K
900 sh
$27.6K
Filed 01/22
Traded 01/20
Mayur Ian SomaiyaCFO
Planned sale10b5-1 planNewAmsterdam Pharma
Planned sale10b5-1 plan
NewAmsterdam Pharma
NAMS
$6.3M
200,000 sh
$6.3M
Filed 01/20
Traded 01/20

Mayur Ian Somaiya, CFO — sold $512.8K of NewAmsterdam Pharma NAMS · 15.7% of holdings · 10b5-1 plan | Whalegun